Literature DB >> 102796

N,N'-(Phenylene)dioxamic acids and their esters as antiallergy agents.

J B Wright, C M Hall, H G Johnson.   

Abstract

A series of dialkyl N,N'-(m-phenylene)dioxamates was synthesized by treatment of the requisite m-phenylenediamines with an alkyloxalyl chloride in the presence of triethylamine. Hydrolysis with sodium hydroxide solution gave the corresponding N,N'-(m-phenylene)dioxamic acids. Several N,N'-(p-phenylene)dioxamic acids were synthesized also in the same manner starting with the requisite p-phenylenediamines. These compounds were tested in the rat passive cutaneous anaphylaxis (PCA) assay. When tested iv, activity was found in the N,N'-(m-phenylene) dioxamic acids up to 2500 times that shown by disodium cromoglycate [50% inhibition at 0.001 mg/kg for N,N'-(2-chloro-5-cyano-m-phenylene)dioxamic acid (compound 61)]. Oral activity was seen in this series of compounds with duration of activity up to 120 min. Oral activity was detected in diethyl N,N'-(2-chloro-5-cyano-m-phenylene)dioxamate (compound 38) at levels of drug as low as 0.1 mg/kg.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 102796     DOI: 10.1021/jm00207a016

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  The effect of lodoxamide ethyl [diethyl N,N'-(2-chloro-5-cyano-m-phenylene)dioxamate] on in vivo anaphylactic reactions.

Authors:  H G Johnson; R L Griffin; J B Wright
Journal:  Agents Actions       Date:  1979-08

2.  Visible light-mediated photocatalytic oxidative cleavage of activated alkynes via hydroamination: a direct approach to oxamates.

Authors:  Narenderreddy Katta; Mamata Ojha; Arumugavel Murugan; Sagar Arepally; Duddu S Sharada
Journal:  RSC Adv       Date:  2020-03-27       Impact factor: 3.361

3.  Convenient conversion of hazardous nitrobenzene derivatives to aniline analogues by Ag nanoparticles, stabilized on a naturally magnetic pumice/chitosan substrate.

Authors:  Reza Taheri-Ledari; Seyedeh Shadi Mirmohammadi; Kobra Valadi; Ali Maleki; Ahmed Esmail Shalan
Journal:  RSC Adv       Date:  2020-12-08       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.